Lavni Ventures raises $21M for second deep-tech fund
What's the deal? Lavni VenturesDealroom has a profile for this one. Try Dealroom → has closed its second fund at US$27.2M, targeting early-stage deep-tech startups in India. The firm reached its target after an initial close in August 2025 and holds a green-shoe option of US$13.6M.
What's the endgame? Fund II backs foundational technologies in health and climate, building on the fully invested Fund I. It plans to write US$271.6K–US$814.8K ($210,000–$630,000) cheques at seed, with follow-on rounds of US$1.09M–US$2.04M ($850,000–$1.5 million) for Series A and beyond.
Why now? With the target corpus committed, Lavni is shifting focus to deployment. It has already made its first three investments: Padcare LabsDealroom has a profile for this one. Try Dealroom →, which recycles sanitary waste; Monitra HealthcareDealroom has a profile for this one. Try Dealroom →, which develops remote cardiac monitoring devices; and VidcareDealroom has a profile for this one. Try Dealroom →, which builds portable at-home diagnostic tests.
Founded in 2020, Lavni Ventures is a SEBI-registered Category II Alternative Investment Fund operating under the Lavni Ventures Trust. Both funds rest on the premise that Indian deep-tech founders can build globally scalable solutions in health and climate while staying capital efficient.
The signal: The raise reflects continued investor appetite for deep-tech in India, where health and climate startups are drawing capital aimed at long-term, foundational bets rather than quick returns.
Read more: startupsuperb.com
Image credit: Generated with Gemini
